BUY NOW For Sale 70%!
buy viagra

Stenotrophomonas maltophilia ciprofloxacin

WARNINGS

FOR TOPICAL OPHTHALMIC USE ONLY.

NOT FOR INJECTION INTO THE EYE.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated.

PRECAUTIONS

General

As with other antibacterial preparations, prolonged use of ciprofloxacin may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated. Whenever clinical judgment dictates, the patient should be examined with the aid of magnification, such as slit lamp biomicroscopy and, where appropriate, fluorescein staining. Ciprofloxacin should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity reaction. Ophthalmic ointments may retard corneal healing and cause visual blurring. Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis.

Carcinogenesis, Mutagenesis, Impairment Of Fertility

Eight in vitro mutagenicity tests have been conducted with ciprofloxacin and the test results are listed below:

Salmonella/Microsome Test (Negative)
E. coli DNA Repair Assay (Negative)
Mouse Lymphoma Cell Forward Mutation Assay (Positive)
Chinese Hamster V79 Cell HGPRT Test (Negative)
Syrian Hamster Embryo Cell Transformation Assay (Negative)
Saccharomyces cerevisiae
Point Mutation Assay (Negative)
Saccharomyces cerevisiae
Mitotic ciprofloxacin Crossover and Gene Conversion Assay (Negative)
Rat Hepatocyte DNA Repair Assay (Positive)

Thus, two of the eight tests were positive, but the results of the following three in vivo test systems gave negative results:

Rat Hepatocyte DNA Repair Assay
Micronucleus Test (Mice)
Dominant Lethal Test (Mice)

Long-term carcinogenicity studies in mice and rats have been completed. After daily oral dosing for up to two years, there is no evidence that ciprofloxacin had any carcinogenic or tumorigenic effects in these species.

Pregnancy

Pregnancy Category C. Reproduction studies have been performed in rats and mice at doses up to six times the usual daily human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to ciprofloxacin. In rabbits, as with most antimicrobial agents, ciprofloxacin (30 and 100 mg/kg orally) produced gastrointestinal disturbances resulting in maternal weight loss and an increased incidence of abortion. No teratogenicity was observed at either dose. After intravenous administration, at doses up to 20 mg/kg, no maternal toxicity was produced and no embryotoxicity or teratogenicity was observed. There are no adequate and well controlled studies in pregnant women. CILOXAN® (ciprofloxacin ophthalmic ointment) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers

It is not known whether topically applied ciprofloxacin is excreted in human milk. However, it is known that orally administered ciprofloxacin is excreted in the milk of lactating rats and oral ciprofloxacin has been reported in human breast milk after a single 500 mg dose. Caution should be exercised when CILOXAN® (ciprofloxacin ophthalmic ointment) is administered to a nursing mother.

Pediatric Use

Safety and effectiveness of CILOXAN® (ciprofloxacin ophthalmic ointment) 0.3% in pediatric patients below the age of two years have not been established. Although ciprofloxacin and other quinolones may cause arthropathy in immature Beagle dogs after oral administration, topical ocular administration of ciprofloxacin to immature animals did not cause any arthropathy and there is no evidence that the ophthalmic dosage form has any effect on the weight bearing joints.

Geriatric Use

No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.


Source: http://www.rxlist.com/ciloxan-ophthalmic-ointment-drug.htm


BUY NOW For Sale 70%!
buy viagra

Tratamiento con antibiticos para Stenotrophomonas Uroxin 500 ciprofloxacin 250

Stenotrophomonas maltophilia ciprofloxacin Stenotrophomonas maltophilia - SciELO
Stenotrophomonas maltophilia ciprofloxacin (Stenotrophomonas)
Stenotrophomonas maltophilia ciprofloxacin CILODEX 3 mg/ml / 1 mg/ml ear drops, suspension
Stenotrophomonas maltophilia ciprofloxacin CIPRO
Stenotrophomonas maltophilia ciprofloxacin Cipro (ciprofloxacin) Antibiotic Side Effects, Adverse Events
Stenotrophomonas maltophilia ciprofloxacin Ebook - Wikipedia
Stenotrophomonas maltophilia ciprofloxacin Enterococcus faecalis - Bacterial strain, organism
Stenotrophomonas maltophilia ciprofloxacin Epocrates Drug Updates
Erotiskais horoskops: Skorpions eHoroskopi Infectie urinara sange urina JuJa Italia Most Common Drugs MediMoon Natural Antibiotics that Fight Infection A Guide to Natural Painting plasterboard - seal or not? - m Proudly South African - Business Site - How to Register
BUY NOW For Sale 70%!
buy viagra